WHO ICTRP trial
Primary Irritation Patch Test on subjects with normal skin.
CTRI/2024/02/062965 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2024/02/062965 |
|---|---|
| Public title | Primary Irritation Patch Test on subjects with normal skin. |
| Scientific title | Evaluation of Dermatological Safety of Test Products by 24 Hours Patch Test under Complete Occlusion on Adult Healthy Human Participants with Normal Skin. - NIL |
| Primary sponsor | DPKA Universal Consumer Ventures Private Limited |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | India |
| Interventions | Intervention1: Face Cleanser: 8%w/v sample solution, 0.04mg, single dose, topical application, 24 hr Control Intervention1: Positive Control: 1 gm of SLS in 100 mL of distilled water (1 % w/v) , 0.04 mg, single dose, topical application, 24… |
| Registration date | Feb 21, 2024 |
| Target size | 26 |
| Secondary IDs | C3B03444-DPK-D, Version: 01, Dated 30 Jan 24 |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: